BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 32708519)

  • 1. Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.
    Dominguez-Valentin M; Seppälä TT; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Sampson JR; Ryan NAJ; Evans DG; Møller P; Crosbie EJ
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer.
    Adachi M; Banno K; Yanokura M; Iida M; Nakamura K; Nogami Y; Umene K; Masuda K; Kisu I; Ueki A; Hirasawa A; Tominaga E; Aoki D
    Mol Clin Oncol; 2015 Mar; 3(2):267-273. PubMed ID: 25798252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
    Crosbie EJ; Ryan NAJ; Arends MJ; Bosse T; Burn J; Cornes JM; Crawford R; Eccles D; Frayling IM; Ghaem-Maghami S; Hampel H; Kauff ND; Kitchener HC; Kitson SJ; Manchanda R; McMahon RFT; Monahan KJ; Menon U; Møller P; Möslein G; Rosenthal A; Sasieni P; Seif MW; Singh N; Skarrott P; Snowsill TM; Steele R; Tischkowitz M; ; Evans DG
    Genet Med; 2019 Oct; 21(10):2390-2400. PubMed ID: 30918358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch Syndrome: Awareness among Medical Students at a United States Medical School.
    Frey MK; Biewald MA; Worley MJ; Taylor JS; Lin SN; Holcomb K
    Curr Womens Health Rev; 2012 Aug; 8(3):242-247. PubMed ID: 23316129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process.
    Zhao L; Lynch L; Eiriksson L
    Hered Cancer Clin Pract; 2024 May; 22(1):5. PubMed ID: 38698439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental placenta increta at the time of prophylactic hysterectomy for Lynch syndrome: Insights into individualized decision-making and surgical timing.
    Nielsen TA; David SN; Desouki MM; Crispens MA; Khabele D
    Gynecol Oncol Rep; 2015 Nov; 14():20-2. PubMed ID: 26793766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for balanced health policies to avoid path dependent medicine.
    Takian A
    Int J Health Policy Manag; 2013 Jun; 1(1):3-5. PubMed ID: 24596830
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Nakken S; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Ryan N; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Auranen A; Hopper JL; Win AK; Haile RW; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Okkels H; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Sampson JR; Evans DG; Seppälä TT; Møller P
    Genet Med; 2021 Apr; 23(4):705-712. PubMed ID: 33257847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.
    Pietragalla A; Arcieri M; Marchetti C; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Nov; 30(11):1803-1810. PubMed ID: 32895312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.
    Piombino C; Cortesi L; Lambertini M; Punie K; Grandi G; Toss A
    J Oncol; 2020; 2020():6384190. PubMed ID: 32733558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum.
    Dominguez-Valentin M; Sampson JR; Møller P; Seppälä TT;
    Int J Cancer; 2021 Jan; 148(2):512-513. PubMed ID: 32783184
    [No Abstract]   [Full Text] [Related]  

  • 12. The Management of Peutz-Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline.
    Wagner A; Aretz S; Auranen A; Bruno MJ; Cavestro GM; Crosbie EJ; Goverde A; Jelsig AM; Latchford A; Leerdam MEV; Lepisto A; Puzzono M; Winship I; Zuber V; Möslein G
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33513864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
    Faughnan ME; Mager JJ; Hetts SW; Palda VA; Lang-Robertson K; Buscarini E; Deslandres E; Kasthuri RS; Lausman A; Poetker D; Ratjen F; Chesnutt MS; Clancy M; Whitehead KJ; Al-Samkari H; Chakinala M; Conrad M; Cortes D; Crocione C; Darling J; de Gussem E; Derksen C; Dupuis-Girod S; Foy P; Geisthoff U; Gossage JR; Hammill A; Heimdal K; Henderson K; Iyer VN; Kjeldsen AD; Komiyama M; Korenblatt K; McDonald J; McMahon J; McWilliams J; Meek ME; Mei-Zahav M; Olitsky S; Palmer S; Pantalone R; Piccirillo JF; Plahn B; Porteous MEM; Post MC; Radovanovic I; Rochon PJ; Rodriguez-Lopez J; Sabba C; Serra M; Shovlin C; Sprecher D; White AJ; Winship I; Zarrabeitia R
    Ann Intern Med; 2020 Dec; 173(12):989-1001. PubMed ID: 32894695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics.
    Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M;
    Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Seppälä TT; Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vida JB; Kariv R; Rosner G; Piñero TA; Pavicic W; Kalfayan P; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Redler S; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Hopper JL; Win AK; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Wadt KAW; Mourits MJE; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Rokkones E; Sampson JR; Evans DG; Møller P
    Eur J Cancer; 2021 May; 148():124-133. PubMed ID: 33743481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.
    Dueñas N; Navarro M; Teulé À; Solanes A; Salinas M; Iglesias S; Munté E; Ponce J; Guardiola J; Kreisler E; Carballas E; Cuadrado M; Matias-Guiu X; de la Ossa N; Lop J; Lázaro C; Capellá G; Pineda M; Brunet J
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33218006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative.
    Spinosa D; Acosta T; Wong J; Kurtovic K; Mewshaw J; Collins S; Kauff N; Havrilesky LJ; Strickland KC; Previs RA
    Gynecol Oncol; 2021 Jan; 160(1):169-174. PubMed ID: 33393478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.
    Lim N; Hickey M; Young GP; Macrae FA; Kelly C
    Int J Gynecol Cancer; 2022 May; 32(5):646-655. PubMed ID: 35437274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.
    Liu YL; Breen K; Catchings A; Ranganathan M; Latham A; Goldfrank DJ; Grisham RN; Long Roche K; Frey MK; Chi DS; Abu-Rustum N; Aghajanian C; Offit K; Stadler ZK
    JCO Oncol Pract; 2022 Mar; 18(3):201-209. PubMed ID: 34582274
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.